Global Longlife Hospital and Research Ltd (GLHRL) — shareholding pattern, promoter holding, financials and share price
About Global Longlife Hospital and Research Ltd (GLHRL)
Global Longlife Hospital and Research Ltd operates in the Hospital industry, within the Healthcare sector. It trades on the NSE as GLHRL and on the BSE under scrip code 543520. Its ISIN is INE0J2K01014.
Incorporated in 2015, Global Longlife Hospital & Research Ltd is in the business of Health Care and Hospitals [1]
Global Longlife Hospital and Research Limited is a Gujarat-based multi-specialty tertiary care hospital with 110 beds, providing comprehensive medical and surgical care.
Founded in 2012 and opening by 2015-16, Global Longlife Hospital was initially a private firm and became public in 2021, reflecting its growth strategy and public investment approach.
Listed peers in Hospital: Shanmuga Hospital Ltd, Sangani Hospitals Ltd, Aatmaj Healthcare Ltd, Soni Medicare Ltd, KK Shah Hospitals Ltd, Broach Lifecare Hospital Ltd.
Valuation & Returns
10 Jul 2026At ₹9.94 a share on 10 Jul 2026, Global Longlife Hospital and Research Ltd (GLHRL) was valued at a price-to-book of 0.44x on a book value of ₹22.62 per share. Solomo computes return on equity of -7.24% and return on capital employed of -4.16% from filed results.
- Industry P/E
- 61.73x
- P/B
- 0.44x
- Book value / share
- ₹22.62
- ROE
- -7.24%
- ROCE
- -4.16%
- ROA
- -7.24%
- Debt / equity
- 0x
- Dividend yield
- 0%
- 52-week range
- ₹9 – ₹26.73
Ratios are computed from filed results and the last recorded price. Not investment advice.
Financial Performance
Mar 2026In the year ended Mar 2026, Global Longlife Hospital and Research Ltd (GLHRL) reported net profit of ₹-1.72 crore and earnings per share of ₹-1.64. Figures are standalone, as filed with the exchanges.
In the quarter ended Mar 2026, net profit ₹-0.4 crore (standalone).
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue (₹ cr) | 32.44 | 23.38 | 13.46 | 0.31 | 0 |
| Net profit (₹ cr) | 3.57 | 1.83 | -2.19 | 0.2 | -1.72 |
| EPS (₹) | 5.1 | 1.74 | -2.09 | 0.19 | -1.64 |
| Measure | 1Y |
|---|---|
| Sales growth | -100.00% |
| Profit growth | -960.00% |
Ownership Summary
Jun 2026As of Jun 2026, promoters hold 22.88% of Global Longlife Hospital and Research Ltd (GLHRL) (unchanged from the previous quarter). Market capitalisation was ₹10 crore on 10 Jul 2026. Shareholding is filed quarterly with BSE and NSE; Solomo carries every filing back to Jun 2022.
Largest disclosed public shareholders in Jun 2026: ATRICHHAYA FINANCIAL PRIVATE LIMITED 3.24%, L7 HITECH PRIVATE LIMITED 3.13%, MANISH UPENDRA SHANGHVI 2.52%, YASHWANTLAL DAXINI 2.38%, JITENDRA BABULAL JAIN 2.38%, YOGESHKUMAR RASIKLAL SANGHAVI 2.24%. Only stakes above the 1% disclosure threshold are named in filings.
| Quarter | Promoter | Pledged | FII | DII | Public |
|---|---|---|---|---|---|
| Jun 2026 | 22.88% | - | - | - | 77.12% |
| Mar 2026 | 22.88% | - | - | - | 77.12% |
| Dec 2025 | 35.44% | - | - | - | 64.56% |
| Sep 2025 | 55.1% | - | - | - | 44.9% |
| Jun 2025 | 54.9% | - | - | - | 45.1% |
| Mar 2025 | 54.29% | - | - | - | 45.71% |
| Dec 2024 | 54.29% | - | - | - | 45.71% |
| Sep 2024 | 54.29% | - | - | - | 45.71% |